Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the non-ATP-binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T-cell lymphoma (CTCL). | FEBS Lett | 2021 | 34455585 | PubTator, text mining | PubMed |
| Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling. | Stem Cell Res Ther | 2021 | 34454603 | PubTator, text mining | PubMed |
| Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK. | Proc Natl Acad Sci U S A | 2021 | 34452995 | PubTator, text mining | PubMed |
| Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration. | Int J Mol Sci | 2021 | 34445786 | PubTator, text mining | PubMed |
| CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation. | Int J Mol Sci | 2021 | 34445576 | PubTator, text mining | PubMed |
| Role of Nuclear Factor of Activated T Cells (NFAT) Pathway in Regulating Autophagy and Inflammation in Retinal Pigment Epithelial Cells. | Int J Mol Sci | 2021 | 34445390 | PubTator, text mining | PubMed |
| WNT Signaling as a Therapeutic Target for Glioblastoma. | Int J Mol Sci | 2021 | 34445128 | PubTator, text mining | PubMed |
| Delivery of the VIVIT Peptide to Human Glioma Cells to Interfere with Calcineurin-NFAT Signaling. | Molecules | 2021 | 34443374 | PubTator, text mining | PubMed |
| Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs. | J Pers Med | 2021 | 34442365 | PubTator, text mining | PubMed |
| Age as a Prognostic Factor in Patients with Ewing Sarcoma-The Polish Sarcoma Group Experience. | J Clin Med | 2021 | 34441922 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Melanoma: Facts and Hopes. | Cells | 2021 | 34440824 | PubTator, text mining | PubMed |
| PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells. | Cancers (Basel) | 2021 | 34439305 | PubTator, text mining | PubMed |
| Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications. | Cancers (Basel) | 2021 | 34439223 | PubTator, text mining | PubMed |
| Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity. | Front Cell Dev Biol | 2021 | 34434936 | PubTator, text mining | PubMed |
| NKD2 mediates stimulation-dependent ORAI1 trafficking to augment Ca2+ entry in T cells. | Cell Rep | 2021 | 34433025 | PubTator, text mining | PubMed |
| Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. | Patterns (N Y) | 2021 | 34430923 | PubTator, text mining | PubMed |
| INFIMA leverages multi-omics model organism data to identify effector genes of human GWAS variants. | Genome Biol | 2021 | 34425882 | PubTator, text mining | PubMed |
| Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia. | Nat Cancer | 2021 | 34423310 | PubTator, text mining | PubMed |
| Journey to the Center of the Cell: Cytoplasmic and Nuclear Actin in Immune Cell Functions. | Front Cell Dev Biol | 2021 | 34422807 | PubTator, text mining | PubMed |
| Calcineurin Activation by Prion Protein Induces Neurotoxicity via Mitochondrial Reactive Oxygen Species. | Oxid Med Cell Longev | 2021 | 34394828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=46